UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 78

Sortiert nach

Sunitinib, a Receptor Tyrosine Kinase Inhibitor, Increases Blood Pressure in Rats without Associated Changes in Cardiac Structure and Function

Cardiovascular therapeutics, 2012-10, Vol.30 (5), p.287-294

2012

Volltextzugriff (PDF)

1892P - Enzalutamide (ENZA) and apalutamide (APA) In vitro chemical reactivity studies and activity in a mouse drug allergy model (MDAM)

Annals of oncology, 2019-10, Vol.30, p.v767-v768

2019

Volltextzugriff (PDF)

Enzalutamide (ENZA) and apalutamide (APA) In vitro chemical reactivity studies and activity in a mouse drug allergy model (MDAM)

Annals of oncology, 2019-10, Vol.30, p.v767-v768

2019

Volltextzugriff (PDF)

Mechanistic investigations of kinase inhibitor-mediated hypotension

Journal of pharmacological and toxicological methods, 2017-05, Vol.85, p.89-89

2017

Volltextzugriff (PDF)

Frequency of multiple changes to prespecified primary outcomes of clinical trials completed between 2009 and 2017 in German university medical centers: A meta-research study

PLoS medicine, 2023-10, Vol.20 (10), p.e1004306-e1004306

2023

Volltextzugriff (PDF)

Premature Discontinuation of Pediatric Randomized Controlled Trials: A Retrospective Cohort Study

The Journal of pediatrics, 2017-05, Vol.184, p.209-214.e1

2017

Volltextzugriff (PDF)

1892PEnzalutamide (ENZA) and apalutamide (APA) In vitro chemical reactivity studies and activity in a mouse drug allergy model (MDAM)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Blood pressure and cardiac structure and function evaluation following treatment with sunitinib (SU11248, Sutent®)

Journal of pharmacological and toxicological methods, 2008-09, Vol.58 (2), p.172-172

2008

Volltextzugriff (PDF)

USE OF RAT ISOLATED-AORTA TISSUE BATH ASSAY AS A RANK-ORDER SCREENING METHOD FOR IN VIVO HEMODYNAMIC EFFECTS

Journal of pharmacological and toxicological methods, 2007-09, Vol.56 (2), p.e29-e29

2007

Volltextzugriff (PDF)

Current use of routinely collected health data to complement randomized controlled trials: a meta-epidemiological survey

CMAJ open, 2016-04, Vol.4 (2), p.E132-E140

2016

Volltextzugriff (PDF)

Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis

JAMA : the journal of the American Medical Association, 2021-03, Vol.325 (12), p.1185

2021

Volltextzugriff (PDF)

The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)

BMJ (Online), 2018-11, Vol.363, p.k3532

2018

Volltextzugriff (PDF)

Searching two or more databases decreased the risk of missing relevant studies: a metaresearch study

Journal of clinical epidemiology, 2022-09, Vol.149, p.154-164

2022

Volltextzugriff (PDF)

Association between ambient air pollution and diabetes mellitus in Europe and North America: systematic review and meta-analysis

Environmental health perspectives, 2015-05, Vol.123 (5), p.381-381

2015

Volltextzugriff (PDF)

Prevalence, characteristics, and publication of discontinued randomized trials

JAMA : the journal of the American Medical Association, 2014-03, Vol.311 (10), p.1045

2014

Volltextzugriff (PDF)

Ten simple rules for good research practice

PLoS computational biology, 2022-06, Vol.18 (6), p.e1010139-e1010139

2022

Volltextzugriff (PDF)

The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement

PLoS medicine, 2015-10, Vol.12 (10), p.e1001885-e1001885

2015

Volltextzugriff (PDF)

The reporting of studies using routinely collected health data was often insufficient

Journal of clinical epidemiology, 2016-11, Vol.79, p.104-111

2016

Volltextzugriff (PDF)

Rituximab in primary central nervous system lymphoma—A systematic review and meta‐analysis

Hematological oncology, 2019-12, Vol.37 (5), p.548-557

2019

Volltextzugriff (PDF)

The evidence base of US Food and Drug Administration approvals of novel cancer therapies from 2000 to 2020

International journal of cancer, 2023-06, Vol.152 (12), p.2474-2484

2023

Volltextzugriff (PDF)

Strength of Statistical Evidence for the Efficacy of Cancer Drugs: A Bayesian Re-Analysis of Randomized Trials Supporting FDA Approval

Journal of clinical epidemiology, 2024-07, p.111479, Article 111479

2024

Volltextzugriff (PDF)

Characteristics, consent patterns, and challenges of randomized trials using the Trials within Cohorts (TwiCs) design A scoping review

Journal of clinical epidemiology, 2024-07, p.111469, Article 111469

2024

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(71)

Publikationsform

Artikel
(76)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Life Sciences & Biomedicine
(46)
Humans
(32)
Clinical Trials
(19)
General & Internal Medicine
(16)
Medicine, General & Internal
(15)
Epidemiology
(14)
Research Design
(11)
Cohort Studies
(10)
Electronic Health Records
(10)
Health Care Sciences & Services
(10)
Data Collection
(9)
Medical Research
(9)
Public, Environmental & Occupational Health
(9)
Medicin Och Hälsovetenskap
(8)
Randomized Controlled Trials As Topic
(8)
Systematic Review
(8)
Studies
(7)
Biomedical Research
(6)
Covid-19
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Sunitinib, a Receptor Tyrosine Kinase Inhibitor, Increases Blood Pressure in Rats without Associated Changes in Cardiac Structure and Function

1892P - Enzalutamide (ENZA) and apalutamide (APA) In vitro chemical reactivity studies and activity in a mouse drug allergy model (MDAM)

Enzalutamide (ENZA) and apalutamide (APA) In vitro chemical reactivity studies and activity in a mouse drug allergy model (MDAM)

Mechanistic investigations of kinase inhibitor-mediated hypotension

Frequency of multiple changes to prespecified primary outcomes of clinical trials completed between 2009 and 2017 in German university medical centers: A meta-research study

Premature Discontinuation of Pediatric Randomized Controlled Trials: A Retrospective Cohort Study

1892PEnzalutamide (ENZA) and apalutamide (APA) In vitro chemical reactivity studies and activity in a mouse drug allergy model (MDAM)

Blood pressure and cardiac structure and function evaluation following treatment with sunitinib (SU11248, Sutent®)

USE OF RAT ISOLATED-AORTA TISSUE BATH ASSAY AS A RANK-ORDER SCREENING METHOD FOR IN VIVO HEMODYNAMIC EFFECTS

Current use of routinely collected health data to complement randomized controlled trials: a meta-epidemiological survey

Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis

The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)

Searching two or more databases decreased the risk of missing relevant studies: a metaresearch study

CONSORT extension for the reporting of randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE): checklist with explanation and elaboration

Association between ambient air pollution and diabetes mellitus in Europe and North America: systematic review and meta-analysis

Prevalence, characteristics, and publication of discontinued randomized trials

Ten simple rules for good research practice

Community consensus on core open science practices to monitor in biomedicine

The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement

The reporting of studies using routinely collected health data was often insufficient

Rituximab in primary central nervous system lymphoma—A systematic review and meta‐analysis

The evidence base of US Food and Drug Administration approvals of novel cancer therapies from 2000 to 2020

Strength of Statistical Evidence for the Efficacy of Cancer Drugs: A Bayesian Re-Analysis of Randomized Trials Supporting FDA Approval

Methods and results used in the development of a consensus-driven extension to the Consolidated Standards of Reporting Trials (CONSORT) statement for trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE)

Characteristics, consent patterns, and challenges of randomized trials using the Trials within Cohorts (TwiCs) design A scoping review

Suchergebnisse filtern